Frontlight ResearchEarly access
Active, not recruitingNo phase
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Key facts
- Who runs it
- EUROS
- Where
- France4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 120 people, planned
- Started
- 27 Oct 2021
- Expected to end
- Jul 2032
- Type of study
- Observational
- Treatments tested
- Hip arthroplasty
- Record updated
- 20 February 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Patient who received EUROSCUP Fixe
- Patient informed of its participation to the study
- Patient aged between 18 and 80 years old (<80)
Who cannot take part
- Patient presenting a contraindication to EUROSCUP Fixe implantation
- Patient who refused to participate to the study
- Vulnerable subjects
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery.
Read full original descriptionShow less
Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.
As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety
The group in the trial
- EUROSCUP Fixe
120 patients who received EUROSCUP Fixe
Treatment: Hip arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 20 February 2024